Table of Content


Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market definitions
1.3 Market estimation & forecast parameters
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid Sources
1.4.2.2 Public Sources
Chapter 2 Executive Summary
2.1 Erdosteine (API) industry 360 degree synopsis, 2021 - 2027
2.1.1 Business Trends
2.1.2 Regional trends
2.1.3 Application trends
2.1.4 End-use trends
Chapter 3 Erdosteine (API) Industry Insights
3.1 Industry segmentation
3.2 Impact of COVID-19 on the global economy
3.3 Industry ecosystem analysis
3.3.1 Vendor matrix
3.3.2 Distribution channel analysis
3.3.2.1 Distributors/ Suppliers
3.3.2.2 Contract Manufacturing
3.3.3 Impact of COVID-19 on industry value chain
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.4.3 Asia Pacific
3.4.3.1 Japan
3.4.3.2 Australia
3.4.3.3 India
3.5 Technology Landscape
3.5.1 Erdosteine synthesis
3.6 Cost structure analysis, 2020
3.6.1 Standard operating cost
3.6.2 Raw material cost
3.6.3 Labor cost
3.7 Component used in API manufacturing
3.8 Raw material analysis, Impact of COVID-19 on supply
3.8.1 Thioglycolic acid
3.8.2 Chloroacetyl chloride
3.8.3 Isopropyl Alcohol
3.8.4 HCL
3.8.5 Methylene Dichloride
3.9 Impact of COVID-19 on Pricing analysis
3.10 Industry impact forces
3.10.1 Growth drivers
3.10.1.1 North America: Growing trends towards cigarette smoking and exposure to tobacco smoke leading to increase in COPD
3.10.1.2 Europe: Exposure to polluted air quality leading to development of serious medical conditions like bronchitis
3.10.1.3 Asia Pacific: Pharmaceutical market expansion
3.10.2 Industry pitfalls & challenges
3.10.2.1 Limitation of the drug with certain medical condition
3.11 Growth potential analysis, 2020
3.11.1 Emerging business model
3.11.1.1 New product launch
3.11.1.2 Collaboration/ Partnership
3.11.1.3 Acquisition
3.12 Porter’s analysis
3.13 Competitive landscape, 2020
3.13.1 Company market share analysis, 2020
3.13.2 Strategy dashboard
3.13.3 Production capacity by company
3.13.4 Production capacity by region
3.13.5 Impact of COVID-19 on consumer buying behavior
3.14 PESTEL analysis
3.15 Other expectorant market overview
3.16 Overview of final product formulation for erdosteine
3.17 Innovation & sustainability
3.18 Patent landscape
3.19 Impact of COVID-19 on erdosteine demand by end-use
3.19.1 Pharmaceutical
3.19.2 CMOs
3.19.3 Research Institutes
Chapter 4 Erdosteine (API) Market, By Application
4.1 Key application trends
4.2 Bronchitis
4.2.1 Global erdosteine (API) market from bronchitis, 2016 - 2027, (Tons) (USD Million)
4.2.2 Global erdosteine (API) market from bronchitis, by region, 2016 - 2027, (Tons) (USD Million)
4.3 Chronic obstructive pulmonary disease (COPD)
4.3.1 Global erdosteine (API) market from COPD, 2016 - 2027, (Tons) (USD Million)
4.3.2 Global erdosteine (API) market from COPD, by region, 2016 - 2027, (Tons) (USD Million)
4.4 Nasopharyngitis
4.4.1 Global erdosteine (API) market from nasopharyngitis, 2016 - 2027, (Tons) (USD Million)
4.4.2 Global erdosteine (API) market from nasopharyngitis, by region, 2016 - 2027, (Tons) (USD Million)
4.5 Others
4.5.1 Global erdosteine (API) market from other application, 2016 - 2027, (Tons) (USD Million)
4.5.2 Global erdosteine (API) market from other application, by region, 2016 - 2027, (Tons) (USD Million)
Chapter 5 Erdosteine (API) Market, By End-Use
5.1 Key end-use trends
5.2 Pharmaceutical
5.2.1 Global erdosteine (API) market from pharmaceutical, 2016 - 2027, (Tons) (USD Million)
5.2.2 Global erdosteine (API) market from pharmaceutical, by region, 2016 - 2027, (Tons) (USD Million)
5.3 Contract manufacturing companies (CMO’s)
5.3.1 Global erdosteine (API) market from Contract manufacturing companies, 2016 - 2027, (Tons) (USD Million)
5.3.2 Global erdosteine (API) market from CMOs, by region, 2016 - 2027, (Tons) (USD Million)
5.4 Research Institute
5.4.1 Global erdosteine (API) market from research institute, 2016 - 2027, (Tons) (USD Million)
5.4.2 Global erdosteine (API) market from research institute, by region, 2016 - 2027, (Tons) (USD Million)
Chapter 6 Erdosteine (API) Market, By Region
6.1 Key regional trends
6.2 Latin America (LATAM)
6.2.1 LATAM erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)
6.2.2 LATAM erdosteine (API) market, by application, 2016 - 2027, (Tons) (USD Million)
6.2.3 LATAM erdosteine (API) market, by end-use, 2016 - 2027, (Tons) (USD Million)
6.2.4 Brazil
6.2.4.1 Brazil erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)
6.2.4.2 Brazil erdosteine (API) market, by application, 2016 - 2027, (Tons) (USD Million)
6.2.4.3 Brazil erdosteine (API) market, by end-use, 2016 - 2027, (Tons) (USD Million)
6.3 Middle East & Africa (MEA)
6.3.1 MEA erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)
6.3.2 MEA erdosteine (API) market, by application, 2016 - 2027, (Tons) (USD Million)
6.3.3 MEA erdosteine (API) market, by end-use, 2016 - 2027, (Tons) (USD Million)
6.3.4 Saudi Arabia
6.3.4.1 Saudi Arabia erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)
6.3.4.2 Saudi Arabia erdosteine (API) market, by application, 2016 - 2027, (Tons) (USD Million)
6.3.4.3 Saudi Arabia erdosteine (API) market, by end-use, 2016 - 2027, (Tons) (USD Million)
6.3.5 South Africa
6.3.5.1 South Africa erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)
6.3.5.2 South Africa erdosteine (API) market, by application, 2016 - 2027, (Tons) (USD Million)
6.3.5.3 South Africa erdosteine (API) market, by end-use, 2016 - 2027, (Tons) (USD Million)
6.3.6 UAE
6.3.6.1 UAE erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)
6.3.6.2 UAE erdosteine (API) market, by application, 2016 - 2027, (Tons) (USD Million)
6.3.6.3 UAE erdosteine (API) market, by end-use, 2016 - 2027, (Tons) (USD Million)
Chapter 7 Company Profiles
7.1 Recipharm AB
7.1.1 Business Overview
7.1.2 Financial Data
7.1.3 Product Landscape
7.1.4 SWOT Analysis
7.1.5 Strategic Outlook
7.2 Taj Pharmaceuticals Limited
7.2.1 Business Overview
7.2.2 Financial Data
7.2.3 Product Landscape
7.2.4 SWOT Analysis
7.3 Wuhan Hezhong Bio-Chemical Manufacture Co., Ltd.
7.3.1 Business Overview
7.3.2 Financial Data
7.3.3 Product Landscape
7.3.4 SWOT Analysis
7.4 Delta Finochem Pvt. Ltd.
7.4.1 Business Overview
7.4.2 Financial Data
7.4.3 Product Landscape
7.4.4 SWOT Analysis
7.5 Alitair Pharmaceuticals, Inc.
7.5.1 Business Overview
7.5.2 Financial Data
7.5.3 Product Landscape
7.5.4 SWOT Analysis
7.6 Salvavidas Pharmaceutical Private Limited
7.6.1 Business Overview
7.6.2 Financial Data
7.6.3 Product Landscape
7.6.4 SWOT Analysis
7.7 Zhejiang Kangle Pharmaceutical Co., Ltd.
7.7.1 Business Overview
7.7.2 Financial Data
7.7.3 Product Landscape
7.7.4 SWOT Analysis
7.8 Wuhan Yuancheng Pharmaceutical
7.8.1 Business Overview
7.8.2 Financial Data
7.8.3 Product Landscape
7.8.4 SWOT Analysis
7.9 Hanmi Pharmaceuticals Co., Ltd.
7.9.1 Business Overview
7.9.2 Financial Data
7.9.3 Product Landscape
7.9.4 SWOT Analysis
7.10 Shandong Luoxin Pharmaceutical
7.10.1 Business Overview
7.10.2 Financial Data
7.10.3 Product Landscape
7.10.4 SWOT Analysis
7.11 Asmoh Laboratories Ltd.
7.11.1 Business Overview
7.11.2 Financial Data
7.11.3 Product Landscape
7.11.4 SWOT Analysis
7.12 Hikma Pharmaceuticals
7.12.1 Business Overview
7.12.2 Financial Data
7.12.3 Product Landscape
7.12.4 SWOT Analysis
7.13 Jigs Chemical
7.13.1 Business Overview
7.13.2 Financial Data
7.13.3 Product Landscape
7.13.4 SWOT Analysis



List of Tables

Data Tables
TABLE 1 Erdosteine (API) industry 360 degree synopsis, 2021 - 2027
TABLE 2 Global erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)
TABLE 3 Global erdosteine (API) market volume, by region, 2013-2024 (Tons)
TABLE 4 Global erdosteine (API) market revenue, by region, 2013-2024 (USD Million)
TABLE 5 Global erdosteine (API) market volume, by application, 2016 - 2027, (Tons)
TABLE 6 Global erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)
TABLE 7 Global erdosteine (API) market volume, by end-use, 2016 - 2027 (Tons)
TABLE 8 Global erdosteine (API) market revenue, by end-use, 2016 - 2027 (USD Million)
TABLE 9 Vendor matrix
TABLE 10 Erdosteine (API) distribution channel analysis
TABLE 11 Operating cost distribution
TABLE 12 Industry impact forces
TABLE 13 Global erdosteine (API) market from bronchitis, 2016 - 2027, (Tons) (USD Million)
TABLE 14 Global erdosteine (API) market volume from bronchitis, by region, 2016 - 2027, (Tons)
TABLE 15 Global erdosteine (API) market revenue from bronchitis, by region, 2016 - 2027, (USD Million)
TABLE 16 Global erdosteine (API) market from COPD, 2016 - 2027, (Tons) (USD Million)
TABLE 17 Global erdosteine (API) market volume from COPD, by region, 2016 - 2027, (Tons)
TABLE 18 Global erdosteine (API) market revenue from COPD, by region, 2016 - 2027, (USD Million)
TABLE 19 Global erdosteine (API) market from nasopharyngitis, 2016 - 2027, (Tons) (USD Million)
TABLE 20 Global erdosteine (API) market volume from nasopharyngitis, by region, 2016 - 2027, (Tons)
TABLE 21 Global erdosteine (API) market revenue from nasopharyngitis, by region, 2016 - 2027, (USD Million)
TABLE 22 Global erdosteine (API) market from other application, 2016 - 2027, (Tons) (USD Million)
TABLE 23 Global erdosteine (API) market volume from other application, by region, 2016 - 2027, (Tons)
TABLE 24 Global erdosteine (API) market revenue from other application, by region, 2016 - 2027, (USD Million)
TABLE 25 Global erdosteine (API) market from pharmaceutical, 2016 - 2027, (Tons) (USD Million)
TABLE 26 Global erdosteine (API) market volume from pharmaceutical, by region, 2016 - 2027, (Tons)
TABLE 27 Global erdosteine (API) market revenue from pharmaceutical, by region, 2016 - 2027, (USD Million)
TABLE 28 Global erdosteine (API) market from CMOs, 2016 - 2027, (Tons) (USD Million)
TABLE 29 Global erdosteine (API) market volume from CMOs, by region, 2016 - 2027, (Tons)
TABLE 30 Global erdosteine (API) market revenue from CMOs, by region, 2016 - 2027, (USD Million)
TABLE 31 Global erdosteine (API) market from research institute, 2016 - 2027, (Tons) (USD Million)
TABLE 32 Global erdosteine (API) market volume from research institute, by region, 2016 - 2027, (Tons)
TABLE 33 Global erdosteine (API) market revenue from research institute, by region, 2016 - 2027, (USD Million)
TABLE 34 LATAM erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)
TABLE 35 LATAM erdosteine (API) market volume, by application, 2016 - 2027, (Tons)
TABLE 36 LATAM erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)
TABLE 37 LATAM erdosteine (API) market volume, by end-use, 2016 - 2027, (Tons)
TABLE 38 LATAM erdosteine (API) market revenue, by end-use, 2016 - 2027, (USD Million)
TABLE 39 Brazil erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)
TABLE 40 Brazil erdosteine (API) market volume, by application, 2016 - 2027, (Tons)
TABLE 41 Brazil erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)
TABLE 42 Brazil erdosteine (API) market volume, by end-use, 2016 - 2027, (Tons)
TABLE 43 Brazil erdosteine (API) market revenue, by end-use, 2016 - 2027, (USD Million)
TABLE 44 MEA erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)
TABLE 45 MEA erdosteine (API) market volume, by application, 2016 - 2027, (Tons)
TABLE 46 MEA erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)
TABLE 47 MEA erdosteine (API) market volume, by end-use, 2016 - 2027, (Tons)
TABLE 48 MEA erdosteine (API) market revenue, by end-use, 2016 - 2027, (USD Million)
TABLE 49 Saudi Arabia erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)
TABLE 50 Saudi Arabia erdosteine (API) market volume, by application, 2016 - 2027, (Tons)
TABLE 51 Saudi Arabia erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)
TABLE 52 Saudi Arabia erdosteine (API) market volume, by end-use, 2016 - 2027, (Tons)
TABLE 53 Saudi Arabia erdosteine (API) market revenue, by end-use, 2016 - 2027, (USD Million)
TABLE 54 South Africa erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)
TABLE 55 South Africa erdosteine (API) market volume, by application, 2016 - 2027, (Tons)
TABLE 56 South Africa erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)
TABLE 57 South Africa erdosteine (API) market volume, by end-use, 2016 - 2027, (Tons)
TABLE 58 South Africa erdosteine (API) market revenue, by end-use, 2016 - 2027, (USD Million)
TABLE 59 UAE erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)
TABLE 60 UAE erdosteine (API) market volume, by application, 2016 - 2027, (Tons)
TABLE 61 UAE erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)
TABLE 62 UAE erdosteine (API) market volume, by end-use, 2016 - 2027, (Tons)
TABLE 63 UAE erdosteine (API) market revenue, by end-use, 2016 - 2027, (USD Million)

Charts & Figures
FIG. 1 Air pollution sources, 2017, (% share)
FIG. 2 Lung disease contributing to estimated current annual deaths, 2018, (% share)
FIG. 3 Chronic Obstructive pulmonary disease 35 years and over, 2017, (% share)
FIG. 4 Chronic Obstructive pulmonary disease 35 years and over, 2017, ()
FIG. 5 Industry segmentation
FIG. 6 Industry ecosystem analysis
FIG. 7 Value chain of generic pharmaceuticals
FIG. 8 Erdosteine synthesis
FIG. 9 New Microfluidic Technique & Continuous Process Method
FIG. 10 Cost structure of API manufacturing, 2020, (% share)
FIG. 11 Raw material break-up for erdosteine, 2020, (% share)
FIG. 12 Reactor Types
FIG. 13 Thioglycolic acid market estimates & forecast, 2016 - 2027, (Kilo Ton)
FIG. 14 Chloroacetyl chloride market estimates & forecast, 2016 - 2027, (USD Million)
FIG. 15 Isopropyl alcohol market estimates & forecast, 2016 - 2027, (USD Million)
FIG. 16 Hydrochloric acid market estimates & forecast, 2016 - 2027, (USD Billion)
FIG. 17 Methylene dichloride market estimates & forecast, 2016 - 2027, (USD Million)
FIG. 18 Erdosteine (API) ex-factory price, 2016-2027, (USD/kilo)
FIG. 19 North America current cigarette smoking data, by age group, 2017, (% share)
FIG. 20 Tobacco products among high school students, by type, 2018, (% share)
FIG. 21 Asia Pacific pharmaceutical market, 2013-2024, (USD Billion)
FIG. 22 India primary cause of respiratory diseases, (% share), 2017
FIG. 23 Growth potential analysis, 2020
FIG. 24 Porter’s analysis
FIG. 25 Erdosteine (API) company market share analysis, 2020
FIG. 26 Porter’s analysis
FIG. 27 SWOT Analysis, Recipharm AB
FIG. 28 SWOT Analysis, Taj Pharmaceuticals
FIG. 29 SWOT Analysis, Wuhan Hezhong Bio-Chemical Manufacture Co., Ltd
FIG. 30 SWOT Analysis, Delta Finochem Pvt. Ltd
FIG. 31 SWOT Analysis, Alitair Pharmaceuticals Inc.
FIG. 32 SWOT Analysis, Salvavidas Pharmaceutical Private Limited
FIG. 33 SWOT Analysis, Zhejiang Kangle Pharmaceuticals Co., Ltd.
FIG. 34 SWOT Analysis, Wuhan Yuancheng Pharmaceutical
FIG. 35 SWOT Analysis, Hanmi Pharmaceuticals Co., Ltd.
FIG. 36 SWOT Analysis, Shandong Luoxin Pharmaceutical
FIG. 37 SWOT Analysis, Asmoh Laboratories Ltd
FIG. 38 SWOT Analysis, Hikma Pharmaceuticals
FIG. 39 SWOT Analysis, Jigs Chemicals